Last update 14 May 2025

HD-NE02

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HD-NE02, HDNE 02, HDNE02
Target-
Action-
Mechanism-
Therapeutic Areas
Eye Diseases
Active Indication
Dry Eye Syndromes
Inactive Indication-
Originator Organization
Nanjing Hengdao Pharmaceutical Technology Co Ltd.
Active Organization
Nanjing Hengdao Pharmaceutical Technology Co Ltd.Jiangsu Dahongying Hengshun Pharmaceutical Co. Ltd.Jiangsu Dahongying Hengshun Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HD-NE02
CTR20241855
/ CompletedPhase 1
HD-NE02缓释滴眼液在中国健康成人中单次/多次给药的随机、双盲、安慰剂对照的安全性、耐受性及药代动力学特征的Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase I clinical study on the safety, tolerability and pharmacokinetic characteristics of single/multiple administration of HD-NE02 sustained-release eye drops in healthy Chinese adults
CTR20251824
/ Not yet recruitingPhase 2
评价HD-NE02 缓释滴眼液治疗干眼的有效性和安全性的多中心、随机、单盲、安慰剂与阳性对照Ⅱ期临床试验
[Translation] A multicenter, randomized, single-blind, placebo- and active-controlled phase II clinical trial to evaluate the efficacy and safety of HD-NE02 sustained-release eye drops in the treatment of dry eyes
100 Clinical Results associated with HD-NE02
Login to view more data
100 Translational Medicine associated with HD-NE02
Login to view more data
100 Patents (Medical) associated with HD-NE02
Login to view more data
100 Deals associated with HD-NE02
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesPhase 2
China
Nanjing Hengdao Pharmaceutical Technology Co Ltd.
13 May 2025
Dry Eye SyndromesPhase 2
China
Jiangsu Dahongying Hengshun Pharmaceutical Co. Ltd.Jiangsu Dahongying Hengshun Pharmaceutical Co. Ltd.
13 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free